Steven Schnelle focuses his practice on regulatory and transactional matters involving healthcare providers and suppliers, pharmacies, pharmaceutical firms, device manufacturers, and market innovators. Steven provides counsel on a variety of healthcare regulatory and transactional matters, primarily focusing on issues involving the Centers for Medicare and Medicaid Services (CMS), the HHS Office of Inspector General (OIG), the Department of Justice (DOJ) and state agencies. He advises clients on complex reimbursement matters involving governmental and commercial payors, and he provides counsel on state licensing and credentialing issues, as well as corporate practice of the health professions. Steven represents clients in False Claims Act (FCA) qui tam matters, investigations and audits, and in matters involving compliance with the federal and state Anti-Kickback statutes. Steven regularly advises private equity firms, investment banks, commercial lenders, and healthcare and life science companies on healthcare regulatory issues relating to mergers and acquisitions, securities filings and financing in the United States.